Prevalence of metabolic syndrome and obesity in patients with sleep apnea­hypopnea syndrome (OSAHS) at Hospital Universitario San Ignacio

Prevalencia de síndrome metabólico y obesidad en pacientes con síndrome de apnea hipopnea del sueño (SAHOS) en el Hospital Universitario San Ignacio

Published 2012-03-30

Open | Download
PDF (Spanish) FLIP
Issue
Vol. 24 No. 1 (2012)
Section
Research article
How to Cite
Prevalence of metabolic syndrome and obesity in patients with sleep apnea­hypopnea syndrome (OSAHS) at Hospital Universitario San Ignacio.
rev. colomb. neumol. [Internet]. 2012 Mar. 30 [cited 2024 Nov. 24];24(1):18-23. Disponible en: https://doi.org/10.30789/rcneumologia.v24.n1.2012.200
DOI

https://doi.org/10.30789/rcneumologia.v24.n1.2012.200
Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Álvaro Morales, MD., MSc.
Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.
    Patricia Hidalgo Martínez, MD., MSc.
    Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.
      Sandra Amado Garzón, MD.
      Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.
        Libardo Medina López, MD.
        Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.
          Show authors biography

          Álvaro Morales, MD., MSc.,

          Internista. Unidad de Epidemiología Clínica, Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.

          Patricia Hidalgo Martínez, MD., MSc.,

          Internista, Neumóloga. Unidad de Neumología, Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.

          Sandra Amado Garzón, MD.,

          Internista, Departamento de Medicina Interna, Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.

          Libardo Medina López, MD.,

          Internista, Departamento de Medicina Interna, Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.

          lntroduction: there is a clear relationship between obstructive sleep apnea-hypopnea syndrome (OSAHS) and overweight; both, in their turn, are associated with increased cardiovascular risk. In Colombia, there is scarce data about the frequency of OSAHS and its association with these factors. In this article, we describe the prevalence of obesity and metabolic syndrome in patients with OSAHS at Hospital Universitario San Ignacio in Bogotá.

          Methods: we describe the frequency of obesity (body mass index greater than 30) in patients with OSA, abdominal perimeter, total cholesterol values, HDL, triglycerides, LDL, fasting blood glucose, and TSH; as well as the differences between patients with and without OSAHS and those with and without metabolic syndrome.

          Results: from the total number of subjects, 215 were diagnosed with OSA (66%), 69 did not have the syndrome (21.4%), and 37 had an invalid polysomnogram. A high prevalence of metabolic syndrome was found in the subgroup of patients that was analyzed. Most of the patients with metabolíc syndrome had OSA, which was not statistically significant (p=O, 155), possibly dueto the fact that it was a small sample of the total poputation. No correlation was found between the Epworth sleepiness scale and the severity of OSA according to the apnea-hypopnea index (r=O, 13).

          Conclusions: in accordance with the literature, this study found a high prevalence of obesity and OSA in the population under study. There was a high rate of coexistence of metabolic syndrome, OSA, and high blood pressure, which confirms the fact that these patients form a group whose cardiovascular risk is high, and therefore require earty intervention.

          Article visits 1450 | PDF visits 665

          Downloads

          Download data is not yet available.
          1. Cirignotta F. Classification and definition of respiratory disorders during sleep. Minerva 2004; 95: 177-85
          2. Bradley D. Sleep apnea and heart failure part I: obstructive sleep apnea. Circulation 2003: 107: 1671-78.
          3. Olson E, Park J. Obstructive sleep apnea-hypopnea syndrome. Prim Care 2005; 32 329-59.
          4. Nisha A, Punjabi. N. Sleep apnea and metabolic dysfunction: cause relation. Sleep Med Clin 2007: 237-50.
          5. Thakkar K, Yao M. Diagnostic studies in obstructive sleep apnea. Otolaryngol Clin N Am 2007, 40: 785-805.
          6. Namyslowsky G .Sleep study in pauents wlth overweight and obesity. J Physcol Pharmacol 2005; 56: 59-65.
          7. Giray N. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005; 28: 1405-11.
          8. Javaherl S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospectiva study. Am J Respir Crit Care Med 2006; 173: 234-7.
          9. Kiwull-Schune HF Low-dose acetazolamide does affect respiratory muscle function in spontaneously breathing anesthetized rabbits.
          10. Am J Respir Crit Care Med 2001; 163: 478-83.
          11. Colln W. Surgical treatment of obstructive sleep apnea. AORN J 2005: 82: 372-74.
          12. Crookes P. Surgical treatment of morbid obesity. Annu Rev Med 2006: 57: 243-264.
          13. Shinji T. Obstructive sleep apnea causes systemic inflammation and metabolic syndrome. Am J Resp Crit Care Med 2004: 169: A430.
          14. Shamsuzzaman A. Elevated e-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-64.
          15. Steven R. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-41.
          16. Harsch I, Hahn EG, Konturek PC. lnsulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. Med Sci Monit 2005; 11: RA70-5.
          17. Vgontzas AN, Bixler EO, Chrousos GP. Apnea is a manifestation of the metabolic syndrome. Sleep Medicine Reviews 2005: 9: 211-24.
          18. Bounhoure JP, Galinier M, Didier A, L.eophonte P. Sleep apnea syndromes and cardiovascular disease. Acad Natl Med 2005: 189: 445-59.
          19. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 2000: 320: 479-82.
          20. Young T, Peppard P, Palla M. Hla KM, Finn L, Margan B, et al. Population-Based Study of Sleep-Disordered Breathing as a risk factor for hypertension. Arch lntern Med 1997; 157: 1746-52.
          21. Peppard P, Young T, Plata M. Prospectiva study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378- 84.
          22. Nieto FJ, Young T. Association of sleep disordered breathing, sleep apnea and hypertension in a large community-based study. JAMA 2000; 283: 1829-36.
          23. Wolk R, Somers VK. Cardiovascular consequences of obstructive sleep apnea. Clin Chest Med 2003; 24: 195-205.
          24. Faccenda J, Mackay T, Boon N, Douglas N. Randomized placebo controlled tryal of continuous positiva airway pressure on pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 344-48.
          25. Maek K, Skatrud J, Finn L, Palta M. The effect of correction of sleep-disordered breathing on BP in untreated hypertension. Chest 2002; 122: 1125-32.
          26. Becker HF, Jerrentrup A. Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH. Effect of nasal continuous positiva airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003: 107: 68-73.
          27. Logan AG. Tkacova R, Perlikowskl Sm, Leung Rs. Tisler A. Floras Js. Refractory hypertension and sleep apnea: effect of CPAP on blood pressure and baroreflex. Eur Resoír J 2003; 21: 241-47.
          28. Barbe F, Mayoralas LR, Durán J, Masa JF. MaimoA, Monstserrat JM. Treatment with continuous positiva airway pressure is not effective In patients with sleep apnea but no oaynrne sleeplness. Ann lnter Med 2001; 134: 1015-23.
          29. Robinson G, Smith D, Langford, B, Davies R, Stradllng J. Continuous positiva airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA pauorus. Eur Respir tns 2006; 27: 1229-35.
          30. Grupo Español de Sueño. Consenso Nacional sobre el síndrome de apneas-hipopneas del sueño. Arch Bronconeumol 2005; 41: 3S-10S.
          31. Schafer H, Koehler U, Ewing S, Hasper E. Tasci S. Luderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999; 92: 79-84.
          32. Shahar E, Whilney C, Redline S, Lee S, Lee S, Newman A, Nieto FJ et al. Sleep-disordered breathing and cardiovascular dreeese. Am Respir Crit Care Med 2001; 163: 19-25.
          33. Franklin K, Nilsson J, Sahlin C. Naslund U. Sleep apnea and nocturnal angina. Lance! 1995; 345: 1085-87.
          34. Mooe T, Franklin K, Wiklund U. Rabben T, Holmstrom K. Sleepdisordered breathing and myocardial ischemia in patlents with coronary artery disease. Chest 2000; 117: 1597-1602.
          35. Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991; 14: 540-54.

          Information

          Journal history

          Keywords

          QR code

          Funding

          Support + Info: Here

           

           

          Directories and indexes

          Google Scholar profile

          Most read in the last 30 days

          Current Issue

          Sistema OJS 3.4.0.7 - Metabiblioteca |